Altimmune ALT Increase Decrease In Income Taxes And Tax Incentive Receivable
Increase Decrease In Income Taxes And Tax Incentive Receivable at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept alt:IncreaseDecreaseInIncomeTaxesAndTaxIncentiveReceivable.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's increase decrease in income taxes and tax incentive receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's increase decrease in income taxes and tax incentive receivable?
- Altimmune (ALT) reported increase decrease in income taxes and tax incentive receivable of -$518K in Q1 2026.
- How has Altimmune's increase decrease in income taxes and tax incentive receivable changed year-over-year?
- Altimmune's increase decrease in income taxes and tax incentive receivable increased by 60.1% year-over-year, from -$1.3M to -$518K.
- What is the long-term trend for Altimmune's increase decrease in income taxes and tax incentive receivable?
- Over 3 years (2021 to 2025), Altimmune's increase decrease in income taxes and tax incentive receivable has grown at a 5.2% compound annual growth rate (CAGR), from -$2.35M to -$2.74M.
- What does increase decrease in income taxes and tax incentive receivable mean?
- This metric tracks the change in receivables related to income tax incentives, credits, or overpayments due from tax authorities. An increase indicates that the company has accrued tax benefits or credits that have not yet been received in cash, while a decrease reflects the collection of these amounts. It provides insight into the company's ability to monetize tax-related assets and manage its tax-related working capital.